Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,15 USD | +1,14% | +7,28% | +34,51% |
Vakgebied
Aantal werknemers: 5
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Rothe
FOU | Founder | 49 | 29-08-06 |
Snehal Patel
CEO | Chief Executive Officer | 60 | 01-02-10 |
David McWilliams
CHM | Chairman | 80 | 01-02-09 |
F. Daugherty
CTO | Chief Tech/Sci/R&D Officer | 73 | 01-09-19 |
Jaye L. Thompson
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-09-19 |
Corporate Officer/Principal | - | 19-04-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David McWilliams
CHM | Chairman | 80 | 01-02-09 |
F. Daugherty
CTO | Chief Tech/Sci/R&D Officer | 73 | 01-09-19 |
Snehal Patel
CEO | Chief Executive Officer | 60 | 01-02-10 |
Eric Rothe
FOU | Founder | 49 | 29-08-06 |
Kenneth Hallock
BRD | Director/Board Member | 75 | 01-09-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 12 879 995 | 6 108 170 ( 47,42 %) | 0 | 47,42 % |
Bedrijfsgegevens
Greenwich LifeSciences, Inc.
3992 Bluebonnet Drive Building 14
77477, Stafford
+
http://www.greenwichlifesciences.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,51% | 181 mln. | |
-0,28% | 90,59 mld. | |
-0,92% | 38,99 mld. | |
-9,57% | 34,09 mld. | |
-17,98% | 15,02 mld. | |
-6,74% | 13,17 mld. | |
-9,76% | 11,88 mld. | |
-47,31% | 10,65 mld. | |
+7,12% | 9,25 mld. | |
+137,06% | 9,02 mld. |
- Beurs
- Aandelen
- Koers GLSI
- Onderneming Greenwich LifeSciences, Inc.